EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Recent advances in targeted therapy for inflammatory vascular diseases

Kaiwen Zhao, Zan Zeng, Yuzhen He, Rong Zhao, Jinzhu Niu, Huiying Sun, Shuangshuang Li, Jian Dong, Zaiping Jing, Jian Zhou

Journal of Controlled Release · 2024

DOI: 10.1016/j.jconrel.2024.06.063 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Controlled Release, 2024. Verfasst von Kaiwen Zhao und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Vascular Surgery, The First Affiliated Hospital, Naval Medical University, Shanghai, China. Hauptthemen laut MEDLINE: Vascular Diseases, Inflammation, Anti-Inflammatory Agents. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 237 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Innovation Talent Promotion Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Vascular diseases constitute a significant contributor to worldwide mortality rates, placing a substantial strain on healthcare systems and socio-economic aspects. They are closely associated with inflammatory responses, as sustained inflammation could impact endothelial function, the release of inflammatory mediators, and platelet activation, thus accelerating the progression of vascular diseases. Consequently, directing therapeutic efforts towards mitigating inflammation represents a crucial approach in the management of vascular diseases. Traditional anti-inflammatory medications may have extensive effects on multiple tissues and organs when absorbed through the bloodstream. Conversely, treatments targeting inflammatory vascular diseases, such as monoclonal antibodies, drug-eluting stents, and nano-drugs, can achieve more precise effects, including precise intervention, minimal non-specific effects, and prolonged efficacy. In addition, personalized therapy is an important development trend in targeted therapy for inflammatory vascular diseases. Leveraging advanced simulation algorithms and clinical trial data, treatment strategies are gradually being personalized based on patients' genetic, biomarker, and clinical profiles. It is expected that the application of precision medicine in the field of vascular diseases will have a broader future. In conclusion, targeting therapies offer enhanced safety and efficacy compared to conventional medications; investigating novel targeting therapies and promoting clinical transformation may be a promising direction in improving the prognosis of patients with inflammatory vascular diseases. This article reviews the pathogenesis of inflammatory vascular diseases and presents a comprehensive overview of the potential for targeted therapies in managing this condition.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vascular DiseasesInflammationAnti-Inflammatory AgentsHumansAnimalsPrecision MedicineDrug Delivery SystemsDrug-Eluting Stents

Stichwörter der Autor:innen

Drug-eluting stentsInflammationMonoclonal antibodiesNanoparticlesTargeted therapyVascular disease

Substanzen

Anti-Inflammatory Agents

Autor:innen und Institutionen

  • Department of Vascular Surgery, The First Affiliated Hospital, Naval Medical University, Shanghai, China.
  • Department of Vascular Surgery, Eastern Hepatobiliary Surgery Hospital, Naval Medical University, Shanghai, China.
  • Department of Vascular Surgery, Shanghai TCM-Integrated Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
  • Department of Vascular Surgery, The First Affiliated Hospital, Naval Medical University, Shanghai, China; Department of Vascular Surgery, Eastern Hepatobiliary Surgery Hospital, Naval Medical University, Shanghai, China…

Förderung

  • National Natural Science Foundation of China
  • National Innovation Talent Promotion Program

Zitieren

APA

Zhao, K., Zeng, Z., He, Y., Zhao, R., Niu, J., Sun, H., Li, S., Dong, J., Jing, Z., & Zhou, J. (2024). Recent advances in targeted therapy for inflammatory vascular diseases. Journal of Controlled Release. https://doi.org/10.1016/j.jconrel.2024.06.063

Vancouver

Zhao K, Zeng Z, He Y, Zhao R, Niu J, Sun H, et al. Recent advances in targeted therapy for inflammatory vascular diseases. Journal of Controlled Release. 2024. doi:10.1016/j.jconrel.2024.06.063

BibTeX
@article{Zhao2024,
  author = {Zhao, Kaiwen and Zeng, Zan and He, Yuzhen and Zhao, Rong and Niu, Jinzhu and Sun, Huiying and Li, Shuangshuang and Dong, Jian and Jing, Zaiping and Zhou, Jian},
  title = {Recent advances in targeted therapy for inflammatory vascular diseases},
  journal = {Journal of Controlled Release},
  year = {2024},
  doi = {10.1016/j.jconrel.2024.06.063}
}
Kostenlos starten →